Listed pharmas weakened even in manufacturing-level profitability
It was analyzed the listed pharmaceutical companies’ gross margin/sales ratio is getting weaker and weaker in not only sales, but manufacturing-level profitability.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of KOSPI and KOSDAQ listed pharmaceutical companies’ 2016 operatin...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
